Atazanavir 300 mg
Atazanavir 300 mg is a protease inhibitor indicated for use in boosted antiretroviral regimens, where it plays a key role in suppressing HIV replication when combined with a pharmacokinetic enhancer and other antiretroviral agents, in line with established treatment guidance.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg once daily administered with an appropriate pharmacokinetic booster (such as ritonavir) and in combination with other antiretroviral medicines, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets
Atazanavir 300 mg
Atazanavir 300 mg is a protease inhibitor indicated for use in boosted antiretroviral regimens, where it plays a key role in suppressing HIV replication when combined with a pharmacokinetic enhancer and other antiretroviral agents, in line with established treatment guidance.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg once daily administered with an appropriate pharmacokinetic booster (such as ritonavir) and in combination with other antiretroviral medicines, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets
Atazanavir 300 mg
Atazanavir 300 mg is a protease inhibitor indicated for use in boosted antiretroviral regimens, where it plays a key role in suppressing HIV replication when combined with a pharmacokinetic enhancer and other antiretroviral agents, in line with established treatment guidance.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg once daily administered with an appropriate pharmacokinetic booster (such as ritonavir) and in combination with other antiretroviral medicines, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets